CDC Recommends Annual Flu Vaccinations, Emphasizing Thimerosal-Free Options
The CDC's advisory committee endorses annual flu shots for all ages, highlighting the phase-out of thimerosal and promoting single-dose formulations for children.

CDC committee moves to phase out controversial mercury ingredient from flu vaccines

What is thimerosal? What the research says about the vaccine preservative under fire by RFK Jr.

Federal vaccine panel concludes meeting with flu shot recommendations

RFK Jr’s New Vaccine Advisors Just Recommended Fall Flu Vaccines – But There’s A Catch
Overview
The CDC's vaccine advisory committee unanimously recommends annual flu vaccinations for all Americans aged 6 months and older, emphasizing thimerosal-free options.
Thimerosal, a mercury-based preservative used in vaccines since the 1930s, is being phased out due to controversy, despite health agencies stating no evidence of harm.
Since 2001, thimerosal has been removed from most childhood vaccines, with the exception of multi-dose flu vaccines, which still contain it.
Two panels have recommended flu vaccines without thimerosal, specifically advocating for single-dose formulations for patients under 18 years of age.
Public health experts raise concerns about transparency in vaccine safety discussions and the impact of thimerosal on public perception, despite studies showing no link to autism.
Analysis
Center-leaning sources emphasize scientific consensus on vaccine safety, particularly regarding thimerosal, while dismissing vaccine skepticism as unfounded. They frame the CDC's recommendations as evidence-based, promoting public health and urging vaccination for all. Implicitly, they convey a bias against misinformation and advocate for trust in established health authorities.